⌘K

Login Start Free

Home/Insiders/Lichtlen Peter

LP

SEC Insider//CIK 0001636644

Lichtlen Peter

CIK 00016366441 companyBETHESDA, MD

Transactions

11

Companies

1

Filings

4

CIK

0001636644

Recent Transactions

11 trades

Disposition to Issuer
Sucampo Pharmaceuticals, Inc.
Common Stock, Class A
2018-02-13$18.00/sh−24,000→ 0 total
Disposition to Issuer
Sucampo Pharmaceuticals, Inc.
Stock Option (right to buy)
2018-02-13$13.73/sh−78,200→ 0 total
Disposition to Issuer
Sucampo Pharmaceuticals, Inc.
Stock Option (right to buy)
2018-02-13$10.83/sh−78,200→ 0 total
Disposition to Issuer
Sucampo Pharmaceuticals, Inc.
Stock Option (right to buy)
2018-02-13$11.25/sh−25,000→ 0 total
Disposition to Issuer
Sucampo Pharmaceuticals, Inc.
Stock Option (right to buy)
2018-02-13$3.18/sh−44,000→ 0 total
Disposition to Issuer
Sucampo Pharmaceuticals, Inc.
Stock Option (right to buy)
2018-02-13$4.20/sh−44,000→ 0 total
Disposition to Issuer
Sucampo Pharmaceuticals, Inc.
Stock Option (right to buy)
2018-02-13$6.15/sh−45,000→ 0 total
Award
Sucampo Pharmaceuticals, Inc.
Common stock
2017-03-06+24,000→ 24,000 total
Award
Sucampo Pharmaceuticals, Inc.
Employee Stock Option (right to buy)
2017-03-06+45,000→ 314,400 total
Award
Sucampo Pharmaceuticals, Inc.
Employee Stock Option (right to buy)
2016-03-02+44,000→ 269,400 total
Award
Sucampo Pharmaceuticals, Inc.
Employee Stock Option (right to buy)
2015-03-04+44,000→ 225,400 total

Companies

1

Sucampo Pharmaceuticals, Inc.
Chief Medical Officer

Recent Filings

4

Address

4520 EAST WEST HIGHWAY, 3RD FLOOR

BETHESDA, MD, 20814

View on SEC.gov